Clinical Trials Directory

Trials / Completed

CompletedNCT00806715

Iron Overload in Stem Cell Transplant Recipients

Impact of Iron Overload in Pediatric Patients Undergoing Stem Cell Transplantation

Status
Completed
Phase
Study type
Observational
Enrollment
38 (actual)
Sponsor
Boston Children's Hospital · Academic / Other
Sex
All
Age
5 Years
Healthy volunteers
Not accepted

Summary

The goal of this study is to examine the impact of iron overload in patients undergoing a bone marrow transplant. We believe that the iron status in these patients is associated with complications for transplant survivors. We will examine the iron status in these patients by MRI and by screening for mutations in genes known to cause iron overload. We will also determine the levels of hepcidin (a hormone produced in the liver that appears to regulate iron homeostasis) from blood and urine.

Conditions

Timeline

Start date
2007-02-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2008-12-11
Last updated
2018-03-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00806715. Inclusion in this directory is not an endorsement.